Background: The current medical treatment for hepatitis C is a combination of antiviral therapy along with pegylated interferon alpha and ribavirin. Recent studies have demonstrated that single nucleotide polymorphisms near the interleukin 28B gene coding for IFN-λ3 were associated with the antiviral response. Therefore, this study aimed to determine the frequency of G/T polymorphism of rs8099917 among the Iranian population. Materials and Methods: This cross-sectional study was performed on 93 blood samples (71 sensitive and 22 resistant to treatment) collected from individuals suffering from chronic HCV, and 57 healthy controls. DNA was extracted from the samples and the frequency of the polymorphism was analyzed using the PCR-RFLP method...
Aim: The purpose of this study was to compare the distribution of interleukin (IL)-28B genotypes bet...
Background and objective: Interleukin (IL) 28B single nucleotide polymorphisms (SNP) was recently re...
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 We...
Copyright © 2015 Ahmed Al-Qahtani et al. This is an open access article distributed under the Creati...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
Introduction: Combination of interferon-alpha (IFN-α) and Ribavirin (RBV) drugs is used for tr...
Background: It has been shown that single nucleotide polymorphisms (SNPs) near the interleukin 28B (...
PubMedID: 25857516Background and objective: The hepatitis C virus (HCV) which infects 3% of the worl...
Background: Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue ...
Copyright © 2012 F. Bellanti et al. This is an open access article distributed under the Creative Co...
Background: The gold standard treatment for chronic hepatitis C virus (HCV) infection is pegylated i...
Background & Objectives: Hepatitis C infection is a global health problem because of the high rate p...
Abstract: Chronic hepatitis C (CHC) is a major burden for public health worldwide. Although newer di...
Background The interleukin-28B (IL28B) gene polymorphism is a strong baseline predictor of sustained...
Background: Host genetic factors can affect the progress of hepatitis-C virus (HCV) infection. Inter...
Aim: The purpose of this study was to compare the distribution of interleukin (IL)-28B genotypes bet...
Background and objective: Interleukin (IL) 28B single nucleotide polymorphisms (SNP) was recently re...
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 We...
Copyright © 2015 Ahmed Al-Qahtani et al. This is an open access article distributed under the Creati...
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any m...
Introduction: Combination of interferon-alpha (IFN-α) and Ribavirin (RBV) drugs is used for tr...
Background: It has been shown that single nucleotide polymorphisms (SNPs) near the interleukin 28B (...
PubMedID: 25857516Background and objective: The hepatitis C virus (HCV) which infects 3% of the worl...
Background: Nowadays, the immune response to hepatitis C (HCV) treatment has become a crucial issue ...
Copyright © 2012 F. Bellanti et al. This is an open access article distributed under the Creative Co...
Background: The gold standard treatment for chronic hepatitis C virus (HCV) infection is pegylated i...
Background & Objectives: Hepatitis C infection is a global health problem because of the high rate p...
Abstract: Chronic hepatitis C (CHC) is a major burden for public health worldwide. Although newer di...
Background The interleukin-28B (IL28B) gene polymorphism is a strong baseline predictor of sustained...
Background: Host genetic factors can affect the progress of hepatitis-C virus (HCV) infection. Inter...
Aim: The purpose of this study was to compare the distribution of interleukin (IL)-28B genotypes bet...
Background and objective: Interleukin (IL) 28B single nucleotide polymorphisms (SNP) was recently re...
IL28B polymorphisms do not predict response to therapy in chronic hepatitis C with HCV genotype 5 We...